888
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Association between renal damage markers and carotid atherosclerosis in Afro-descendants with hypertension belonging to a minority ethnic group from Brazil

, , , , , , , & show all
Pages 483-491 | Received 15 Nov 2017, Accepted 28 Jun 2018, Published online: 03 Oct 2018

References

  • Alwan A. Global status report on noncommunicable diseases 2010. Geneva, Switzerland: World Health Organization; 2011.
  • World Health Organization. World Health Statistics 2012. Geneva, Switzerland: World Health Organization; 2012.
  • Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileira de Hipertensão. Arq Bras Cardiol. 2010;95:1–51.
  • Breton CV, Wang X, Mack WJ, et al. Carotid artery intima-media thickness in college students: race/ethnicity matters. Atherosclerosis. 2011;217:441–446.
  • Li S, Chen W, Srinivasan SR, et al. Race (black-white) and gender divergences in the relationship of childhood cardiovascular risk factors to carotid artery intima-media thickness in adulthood: the Bogalusa Heart Study. Atherosclerosis. 2007;194:421–425.
  • Takasu J, Budoff MJ, Katz R, et al. Relationship between common carotid intima-media thickness and thoracic aortic calcification: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2010;209:142–146.
  • Williams JE, Couper DJ, Din-Dzietham R, et al. Race-gender differences in the association of trait anger with subclinical carotid artery atherosclerosis: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2007;165:1296–1304.
  • Manolio TA, Burke GL, Psaty BM, et al. Black-white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. J Clin Epidemiol. 1995;48:1141–1152.
  • Ix JH, Allison MA, Denenberg JO, et al. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study. J Am Coll Cardiol. 2008;51:2347–2354.
  • Gijsberts CM, Groenewegen KA, Hoefer IE, et al. Race/ethnic differences in the associations of the Framingham risk factors with carotid IMT and cardiovascular events. Plos One. 2015;10:e0132321.
  • Wagenknecht LE, Langefeld CD, Freedman BI, et al. A comparison of risk factors for calcified atherosclerotic plaque in the coronary, carotid and abdominal aortic arteries: the Diabetes Heart Study. Am J Epidemiol. 2007;166:340–347.
  • World Health Organization. WHO. Obesity: preventing and Managing the Global Epidemic. Report of a WHO consultation, Geneva, 3–5 Jun 1997. Geneva: World Health Organization; 1998.
  • Sposito AC, Caramelli B, Fonseca FA, et al. IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007;88:2–19.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
  • Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–29.
  • Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr. 2008;21:93–111.
  • Kaul S, Alladi S, Mridula RK, et al. Prevalence and risk factors of carotid intima-media thickness in asymptomatic individual subjects in a tertiary care center in India. Ann Indian Acad Neurol. 2015;18:430–434.
  • Kingue S, Kuaban C, Dongmol L, et al. Ultrasonic demonstration of carotid atherosclerosis in black Cameroonian adults with cardiovascular risk. Ann Cardiol Angeiol (Paris). 1998;47:722–727.
  • Clarke EM, Thompson RC, Allam AH, et al. Is atherosclerosis fundamental to human aging? Lessons from ancient mummies. J Cardiol. 2014;63:329–334.
  • Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res. 2012;111:245–259.
  • McEwen JE, Zimniak P, Mehta JL, et al. Molecular pathology of aging and its implications for senescent coronary atherosclerosis. Curr Opin Cardiol. 2005;20:399–406.
  • Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005; 46:454–462.
  • Silaghi CA, Silaghi H, Crăciun AE, et al. Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease. Med Ultrason. 2015;17:300–307.
  • Binaghi F, Fronteddu PF, Putzu V, et al. Association between carotid lesions evaluated by Doppler color echocardiography and cardiovascular risk factors in the elderly. Preliminary results. Minerva Cardioangiol. 1998;46:217–227.
  • Zhang Y, Agnoletti D, Xu Y, et al. Carotid-femoral pulse wave velocity in the elderly. J Hypertens. 2014;32:1572–1576.
  • Ustundag S, Yilmaz G, Sevinc C, et al. Carotid intima media thickness is independently associated with urinary sodium excretion in patients with chronic kidney disease. Ren Fail. 2015;37:1285–1292.
  • Kidney D. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int (Suppl). 2013;3:1–150.
  • Komenda P, Rigatto C, Tangri N. Estimated glomerular filtration rate and albuminuria: diagnosis, staging, and prognosis. Curr Opin Nephrol Hypertens. 2014;23:251–257.
  • Watanabe S, Okura T, Liu J, et al. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res. 2003;26:895–899.
  • Garimella PS, Ix JH, Katz R, et al. Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2015;65:33–40.
  • Dasmahapatra P, Srinivasan SR, Mokha J, et al. Subclinical atherosclerotic changes related to chronic kidney disease in asymptomatic black and white young adults: the Bogalusa heart study. Ann Epidemiol. 2011;21:311–317.
  • Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313–1320.
  • Freedman BI, Hsu FC, Langefeld CD, et al. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Diabetologia. 2005; 48:2511–2518.
  • Carnethon MR, Bertoni AG, Shea S, et al. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: the Multiethnic Study of Atherosclerosis. Diabetes Care. 2005;28:2768–2770.
  • Divers J, Wagenknecht LE, Bowden DW, et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study. Diabetes Care. 2010;33:131–138.
  • Acheson LS. Bone density and the risk of fractures: should treatment thresholds vary by race?. JAMA. 2005;293:2151–2154.
  • Salgado JV, França AK, Cabral NA, et al. Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension. Rev Assoc Med Bras (1992). 2013;59:21–27.
  • Salgado JV, Souza FL, Salgado BJ. How to understand the association between cystatin C levels and cardiovascular disease: imbalance, counterbalance, or consequence?. J Cardiol. 2013;62:331–335.
  • Shin MJ, Song SH, Kwak IS, et al. Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis. Clin Exp Nephrol. 2012;16:456–463.
  • Keller CR, Odden MC, Fried LF, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007;71:239–244.
  • Skalska A, Klimek E, Wizner B, et al. Kidney function and thickness of carotid intima-media complex in patients with treated arterial hypertension. Blood Press. 2007;16:367–374.
  • Han L, Bai X, Lin H, et al. Lack of independent relationship between age-related kidney function decline and carotid intima-media thickness in a healthy Chinese population. Nephrol Dial Transplant. 2010;25:1859–1865.
  • Bui AL, Katz R, Kestenbaum B, et al. Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2009;53:389–398.
  • Potter K, Hankey GJ, Green DJ, et al. Homocysteine or renal impairment: which is the real cardiovascular risk factor? Arterioscler Thromb Vasc Biol. 2008;28:1158–1164.
  • Monteiro Junior FC, Ferreira PAM, Nunes JAT, et al. Correlação entre a cistatina C sérica e marcadores de aterosclerose subclínica em pacientes hipertensos. Arq Bras Cardiol. 2012;99:899–906.
  • Stone NJ, Robinson JG, Lichtenstein AH, et al. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;63:2889–2934.
  • Ridker PM, Pradhan A, MacFadyen JG, et al. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380:565–571.
  • Bedi US, Singh M, Singh PP, et al. Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal-medial thickness: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2010;15:268–273.
  • Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279:119–124.
  • Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet. 1999;353:1649–1652.